Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 55

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 55
---
uable upon exercise of outstanding warrants at a weighted average exercise price of $15.85 per share; |

| ● | 137,637 shares of common stock issuable upon exercise of outstanding options at a weighted average exercise price of $13.92 per share; and |

| ● | shares of common stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock. |

<div align='center'>26

DILUTION</div>

Purchasers of our securities in this offering will
experience an immediate and substantial dilution in the net tangible book value of their shares of our common stock. Dilution in net tangible
book value represents the difference between the public offering price per share of our common stock and the as adjusted net tangible
book value per share of our common stock immediately after the offering.

The historical net tangible book value of our common
stock as of March 31, 2025 was $3,879,104 or $2.63 per share. Historical net tangible book value per share of our common stock represents
our total tangible assets (total assets less intangible assets) less total liabilities divided by the number of shares of our common stock
outstanding as of that date.

After giving effect to the sale of up to 2,036,659
shares of common stock, or in lieu thereof, Pre-Funded Warrants to purchase up to 2,036,659 shares of common stock, and accompanying
Series A-1 Warrants to purchase up to 2,036,659 shares of common stock and Series A-2 Warrants to purchase up to 2,036,659 shares
of common stock at an assumed public offering price per share of common stock or Pre-Funded Warrant and accompanying Warrants of $2.455,
the last reported sale price of our common stock on The Nasdaq Capital Market on July 2, 2025, assuming exercise in full of any Pre-Funded
Warrants offered in this offering, and after deducting the estimated placement agent fees and estimated offering expenses payable by us,
and excluding the proceeds, if any, from the exercise of the Warrants issued in this offering, our as adjusted net tangible book value
as of March 31, 2025 would have been approximately $8,504,153 million, or approximately $2.42 per share. This represents an immediate
decrease in net tangible book value per share of $0.21 to the existing stockholders and an immediate dilution in